Market Research Logo

Biotechnology in Europe

Biotechnology in Europe

Summary

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The European biotechnology industry had total revenues of $67.9bn in 2017, representing a compound annual growth rate (CAGR) of 5.7% between 2013 and 2017.
  • The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of $43bn, equivalent to 63.4% of the industry's overall value.
  • Italy has now overtaken the UK as the largest market in Europe and the uncertainties of Brexit are thought to have played a part in this. However, the industries in both countries remain close in terms of size, with Germany only slightly behind.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
Reasons to buy
  • What was the size of the Europe biotechnology market by value in 2017?
  • What will be the size of the Europe biotechnology market in 2022?
  • What factors are affecting the strength of competition in the Europe biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Europe's biotechnology market?


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Europe biotechnology industry value: $ billion, 2013-17
Table 2: Europe biotechnology industry category segmentation: $ billion, 2017
Table 3: Europe biotechnology industry geography segmentation: $ billion, 2017
Table 4: Europe biotechnology industry value forecast: $ billion, 2017-22
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Boehringer Ingelheim GmbH: key facts
Table 9: Boehringer Ingelheim GmbH: key financials ($)
Table 10: Boehringer Ingelheim GmbH: key financials (€)
Table 11: Boehringer Ingelheim GmbH: key financial ratios
Table 12: F. Hoffmann-La Roche Ltd: key facts
Table 13: F. Hoffmann-La Roche Ltd: key financials ($)
Table 14: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 15: F. Hoffmann-La Roche Ltd: key financial ratios
Table 16: Merck & Co., Inc.: key facts
Table 17: Merck & Co., Inc.: key financials ($)
Table 18: Merck & Co., Inc.: key financial ratios
List of Figures
Figure 1: Europe biotechnology industry value: $ billion, 2013-17
Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2017
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2017
Figure 4: Europe biotechnology industry value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2017
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2017
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2017
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2017
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2017
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2017
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Boehringer Ingelheim GmbH: revenues & profitability
Figure 14: Boehringer Ingelheim GmbH: assets & liabilities
Figure 15: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 16: F. Hoffmann-La Roche Ltd: assets & liabilities
Figure 17: Merck & Co., Inc.: revenues & profitability
Figure 18: Merck & Co., Inc.: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report